Barcelona, Catalonia, Spain In 1986 was created Corsabe Capital, which is appeared as VC. The company was established in Europe in Spain. The main office of represented VC is situated in the Barcelona.
The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2008. The higher amount of exits for fund were in 2015.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Corsabe Capital, startups are often financed by Najeti Capital, Grupo Intercom, Grupo Ferrer Internacional. The meaningful sponsors for the fund in investment in the same round are Laboratorios Ordesa. In the next rounds fund is usually obtained by Alzheimer's Drug Discovery Foundation.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Spain. Among the most popular portfolio startups of the fund, we may highlight Oryzon Genomics. We can highlight the next thriving fund investment areas, such as Biotechnology, Human Resources.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Oryzon Genomics | $12M | 12 Mar 2008 | Community of Madrid |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Oryzon Genomics | $12M | 12 Mar 2008 | Community of Madrid |
